NunaBio is a spin-out from Newcastle University that manufacturers synthetic DNA at higher purity and lower cost, producing strands of DNA that cannot be produced through traditional solvent based methods.
NunaBio aims to build the next generation of synthetic DNA infrastructure via its proprietary DNA platform which will enable the business to support the rapid production of complex DNA constructs. This will enable faster development of vaccines, gene therapies, diagnostics and other life changing technologies.
This investment marks an important step in scaling a fundamentally new approach to DNA manufacturing. Our focus is on enabling DNA that others cannot produce and translating that capability into a robust, industrial platform. Our long-term vision is a globally deployable network of DNA micro-foundries compact, automated production units applying semiconductor-style manufacturing principles to biology. By standardising and modularising production, we can deliver scalable, high-performance DNA manufacturing without the constraints of traditional approaches.
Joe Hedley, CEO and Co-Founder of NunaBio
Meet the lead executive(s)
Subscribe for email updates
